4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-000976
Director gave up 6,665 shares (to pay taxes)
- Director acquired 17,204 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CANNON JAMES ANTHONY Director | 2016-12-30 | Grant or award | +17,204 | 359,167 | D | ||
| CANNON JAMES ANTHONY Director | 2016-12-31 | Shares withheld for taxes | −6,665 | $5.35 | $35,658 | 352,502 | D |
Loading xslF345X03/doc4.xml…